Company Overview of Cibus Global, Ltd.
Cibus Global, Ltd. develops precision gene editing systems for agricultural, industrial lubricants, food ingredients, and health care markets worldwide. The company focuses on the development of industrial biotechnology, agriculture, and human health and wellness solutions. It offers Rapid Trait Development System (RTDS), a precision gene editing technology that is used to develop new and beneficial characteristics by modifying cell function; Squalane, a clear oil compound that is used in cosmetics, pharmaceuticals, and specialty lubricants; Ergosterol, a natural sterol, which is found in yeast and fungal species; and RTDS illustrations that are scientific documents and available for reprint...
6455 Nancy Ridge Drive
San Diego, CA 92121
Founded in 2001
Key Executives for Cibus Global, Ltd.
Chief Executive Officer and President
Senior Vice President of Research & Development
Head of the Cell Biology Department
Vice President of International Development
Compensation as of Fiscal Year 2014.
Cibus Global, Ltd. Key Developments
Cibus Global Announces Executive Changes
Jul 8 14
Keith Walker, Ph.D., who has led Cibus Global since the company was founded in 2001, has announced his retirement. Rapid Trait Development System developer, and company's Sr. VP of Research and Development Peter Beetham has been tapped to take the top position at the precision gene editing firm. Walker has been named to the Cibus Board of Directors. Dr. Beetham has led the development of the company's core technologies in gene editing that have driven the company's expansion to more than 100 employees with over 70 scientists focusing on advancing company's patented and gene editing technologies. Greg Gocal, Ph.D., the current Vice President of Research at the company, also a member of the founding group has been promoted to Senior Vice President of Research and Development to oversee all research activities at the company. Dr. Gocal, prior to joining the company held research positions and headed the molecular biology group at Valigen.
Cibus Global Appoints Keith Walker as CEO and President
Sep 16 13
Cibus Global announced that Keith Walker, Ph.D., has been appointed as CEO and President. Dr. Walker has held the position of President since the company was founded in 2001. Prior to Cibus, Dr. Walker held a variety of management positions at the Mycogen Corporation, ranging from business development, biotechnology research management and technology in-and-out-licensing.
Similar Private Companies By Industry
Recent Private Companies Transactions
January 6, 2014
October 10, 2013
Most Searched Private Companies
Sponsored Financial Commentaries